HomeRIGL • NASDAQ
add
Rigel Pharmaceuticals Inc
Previous close
$27.25
Day range
$26.53 - $27.52
Year range
$15.50 - $52.24
Market cap
498.77M USD
Avg Volume
366.14K
P/E ratio
1.38
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 69.80M | 21.19% |
Operating expense | 29.99M | 1.60% |
Net income | 268.06M | 1,769.22% |
Net profit margin | 384.04 | 1,442.33% |
Earnings per share | 1.12 | 39.97% |
EBITDA | 23.77M | 37.73% |
Effective tax rate | -1,080.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 154.96M | 100.40% |
Total assets | 513.59M | 213.21% |
Total liabilities | 122.11M | -24.01% |
Total equity | 391.48M | — |
Shares outstanding | 18.47M | — |
Price to book | 1.27 | — |
Return on assets | 15.32% | — |
Return on capital | 18.59% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 268.06M | 1,769.22% |
Cash from operations | 21.98M | 51.55% |
Cash from investing | -25.36M | -132.38% |
Cash from financing | -4.57M | -412.08% |
Net change in cash | -7.95M | -257.38% |
Free cash flow | 14.12M | 970.05% |
About
Founded
1996
Headquarters
Website
Employees
173
